Business Description
3B BlackBio Dx Ltd
ISIN : INE994E01018
Compare
Compare
Traded in other countries / regions
532067.India IPO Date
1996-10-23Description
3B BlackBio Dx Ltd is one of the leading Indian companies in the field of PCR-based Molecular Diagnostic Kits. The Company is ISO 13485:2016 certified, GMP-compliant biotech R&D organization, as an Indo-Spanish JV company and engaged in the design, development, manufacturing and commercialization of PCR based Molecular Diagnostic kits, PCR Enzymes & PCR Reagents.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 44.39 | |||||
| Equity-to-Asset | 0.93 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | 0.03 | |||||
| Interest Coverage | 232.17 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 29.66 | |||||
| Beneish M-Score | -2.51 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 28.9 | |||||
| 3-Year EBITDA Growth Rate | 49.3 | |||||
| 3-Year EPS without NRI Growth Rate | 50 | |||||
| 3-Year FCF Growth Rate | 47.5 | |||||
| 3-Year Book Growth Rate | 74.7 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 64.81 | |||||
| 9-Day RSI | 57.37 | |||||
| 14-Day RSI | 53.06 | |||||
| 6-1 Month Momentum % | 5.89 | |||||
| 12-1 Month Momentum % | 69.32 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 11.9 | |||||
| Quick Ratio | 10.95 | |||||
| Cash Ratio | 5.86 | |||||
| Days Inventory | 150.72 | |||||
| Days Sales Outstanding | 177.84 | |||||
| Days Payable | 57.8 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.33 | |||||
| Dividend Payout Ratio | 0.06 | |||||
| 3-Year Dividend Growth Rate | 27.7 | |||||
| Forward Dividend Yield % | 0.33 | |||||
| 5-Year Yield-on-Cost % | 0.33 | |||||
| Shareholder Yield % | 0.43 |
Profitability Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 70.27 | |||||
| Operating Margin % | 42.76 | |||||
| Net Margin % | 44.3 | |||||
| FCF Margin % | 30.16 | |||||
| ROE % | 17.03 | |||||
| ROA % | 14.25 | |||||
| ROIC % | 13.56 | |||||
| ROC (Joel Greenblatt) % | 74.97 | |||||
| ROCE % | 19.5 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 20.41 | |||||
| PE Ratio without NRI | 20.41 | |||||
| Shiller PE Ratio | 22.42 | |||||
| Price-to-Owner-Earnings | 27.28 | |||||
| PEG Ratio | 0.36 | |||||
| PS Ratio | 9.04 | |||||
| PB Ratio | 2.85 | |||||
| Price-to-Tangible-Book | 2.81 | |||||
| Price-to-Free-Cash-Flow | 28.41 | |||||
| Price-to-Operating-Cash-Flow | 25.9 | |||||
| EV-to-EBIT | 15.64 | |||||
| EV-to-EBITDA | 15.25 | |||||
| EV-to-Revenue | 8.84 | |||||
| EV-to-FCF | 28.38 | |||||
| Price-to-Projected-FCF | 1.22 | |||||
| Price-to-Median-PS-Value | 3.85 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.8 | |||||
| Price-to-Graham-Number | 1.61 | |||||
| Price-to-Net-Current-Asset-Value | 5.59 | |||||
| Price-to-Net-Cash | 13.54 | |||||
| Earnings Yield (Greenblatt) % | 6.4 | |||||
| FCF Yield % | 3.12 | |||||
| Forward Rate of Return (Yacktman) % | 24.7 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
3B BlackBio Dx Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 692.37 | ||
| EPS (TTM) (₹) | 38.779 | ||
| Beta | 0.1 | ||
| Volatility % | 44.03 | ||
| 14-Day RSI | 53.06 | ||
| 14-Day ATR (₹) | 38.947774 | ||
| 20-Day SMA (₹) | 757.77 | ||
| 12-1 Month Momentum % | 69.32 | ||
| 52-Week Range (₹) | 390 - 924 | ||
| Shares Outstanding (Mil) | 8.58 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
3B BlackBio Dx Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
3B BlackBio Dx Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
3B BlackBio Dx Ltd Frequently Asked Questions
What is 3B BlackBio Dx Ltd(BOM:532067)'s stock price today?
The current price of BOM:532067 is ₹780.15. The 52 week high of BOM:532067 is ₹924.00 and 52 week low is ₹390.00.
When is next earnings date of 3B BlackBio Dx Ltd(BOM:532067)?
The next earnings date of 3B BlackBio Dx Ltd(BOM:532067) is .
Does 3B BlackBio Dx Ltd(BOM:532067) pay dividends? If so, how much?
The Dividend Yield %  of 3B BlackBio Dx Ltd(BOM:532067) is 0.33% (As of Today), Highest Dividend Payout Ratio of 3B BlackBio Dx Ltd(BOM:532067) was 0.12. The lowest was 0.02. And the median was 0.06. The  Forward Dividend Yield % of 3B BlackBio Dx Ltd(BOM:532067) is 0.33%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers